A new clinical trial is set to explore the impact of robotic gait training devices on stroke recovery, with particular focus on quality of life, mood, and fatigue.
Robotic rehabilitation technologies are taking another step forward in stroke recovery research. Led by Meltem Gunes Akinci, the upcoming trial plans to analyze how RoboGait® robotic gait training compares with traditional treadmill walking exercises in improving post-stroke conditions including depression, anxiety, fatigue, and overall quality of life. This clinical trial is registered on ClinicalTrials.gov and is not yet recruiting.
In this article:
- What changed?
- What are the intervention details?
- Who is affected?
- FAQs
- Conclusion
- Disclaimer
- Announcement Link
What changed?
The upcoming trial introduces advanced medical device technology in rehabilitation. RoboGait®, a robotic gait training system, will be compared side-by-side with conventional treadmill walking exercises to address functional and emotional recovery beyond motor rehabilitation. This research could offer insights into how robotic devices support patient mental health and fatigue management.
What are the intervention details?
Device Details
RoboGait® Robotic Gait Training: This device facilitates walking movements in patients who require post-stroke rehabilitation. Using robotic assistance, it aims to improve mobility while easing the burden of repetitive treadmill exercises. The device is designed to optimize gait patterns and promote neural recovery.
Treadmill Walking Training: Traditional rehabilitation frequently employs treadmills to support motor improvement. The trial will compare this widely adopted modality with RoboGait® to assess benefits across motor and non-motor outcomes.
Who is affected?
This trial is relevant to:
- Stroke survivors: Individuals dealing with mobility challenges, depression, anxiety, and chronic fatigue post-stroke.
- Clinicians: Healthcare providers interested in advanced rehabilitation modalities for improved patient outcomes.
- Medical device manufacturers: Companies developing robotic technologies for functional recovery.
- Regulatory teams: Professionals seeking data on innovative devices’ performance and safety.
The findings could influence treatment protocols and highlight safety considerations for robotic rehabilitation devices.
FAQs
- What is the focus of this trial? The trial will evaluate how robotic gait training affects depression, anxiety, fatigue, and quality of life in stroke survivors.
- When does recruitment start? Recruitment status currently states “not yet recruiting” on ClinicalTrials.gov as of October 2025.
- Are there safety concerns with RoboGait®? Safety evaluations are part of the trial design to ensure the device meets regulatory standards.
Conclusion
This clinical trial highlights technological innovations in stroke rehabilitation. RoboGait® could redefine how quality of life, mood, and fatigue are addressed in post-stroke recovery. Healthcare teams, manufacturers, and researchers should monitor this study for evolving insights into integrating robotic devices within therapeutic frameworks.
Disclaimer
Information provided here is for educational and regulatory purposes only. It is not legal advice or medical guidance. Always refer to official documents for compliance requirements.
Announcement Link
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07203937?term=medical+device